prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, Qurgical Pathology. CLINICAL HISTORY: Not provided. GROSS EXAMINATION: A. "Left breast biopsy (AF1)" fresh. A 7 x 4.9 x 1.7 cm yellow-white. fibrofatty breast biopsy notable for a 2.5 x 3.5 x 2 cm firm, white lesion. After consultation with Dr. , it was deemed that no surgical margins. or orientation are required on this specimen. The tissue surface is inked in. black, however. Tissue from the lesion is sent to the Tissue Bank for Estrogen. and Progesterone receptor study. The frozen section remnant (AF1) was taken. from the lesion area is submitted in Block A1. A representative sampling from. the lesion area is submitted in Blocks A2-A5. Due to the fact that neither. margins or orientation is an issue in the specimen, only a sampling of the. lesion is taking-- the entire breast biopsy is not submitted. B. "Left breast", fresh. A mastectomy specimen consisting of a 19 x 10 cm. ellipse of skin, a 24 x 15 x 5 cm breast and a 11 x 6 x 3.5 cm axillary tail. The deep surfaces of the breast are inked in black. The skin ellipse contains. the nipple and surrounding areola and is notable for a 4.5 cm freshly sutured. horizontal incision medial to the nipple. The breast specimen is notable for a 7 x 6 x 1.5 cm hollow biopsy cavity lined. by mildly firm, granular red-pink tissue 0.1 cm thick. At its closest point,. the biopsy cavity is 1.5 cm from the posterior surface, 1.7 cm from the. inferior surface, 9 cm from the superior surface, and 1.2 cm from the. overlying anterior skin surface. The remainder of breast is diffusely composed. of yellow-white fibrofatty tissue. No focal lesions are noted. BLOCK SUMMARY: B1- representative section of nipple. B2- representative section of biopsy cavity and closest approach to posterior. surface. B3- representative section of biopsy cavity and closest approach to inferior. surface. B4- biopsy cavity and closest approach to anterior skin surface. B5-B6- additional sections of biopsy cavity. B7-B8- representative sections of upper medial portion of breast. B9-B10- representative sections of lower medial portion of breast. B11-B12- representative sections of upper lateral breast. B13-B14- representative sections of lower portion of breast. B15- four lymph node candidates from most medial portion of axillary tail. B16- four lymph node candidates from mid portion of axillary tail. B17- three lymph node candidates from most lateral portion of axillary tail. B18- three lymph node candidates from most lateral portion of axillary tail. B19- three lymph node candidates from most lateral portion of axillary tail. Dr. INTRA OPERATIVE CONSULTATION: A. "Left breast biopsy" AF1- positive for invasive carcinoma. DIAGNOSIS: A. "LEFT BREAST BIOPSY": INFILTRATING DUCTAL CARCINOMA, HISTOLOGIC GRADE 3, NUCLEAR GRADE 2. N.S.A.B.P. Diagnosis Diss cite. hary. Tumat. (Tircle) primiry SUALIFIED Date 916th. MAXIMUM TUMOR SIZE 3.5 CM. IN SITU DUCTAL COMPONENT REPRESENTS APPROXIMATELY 15 TO 20% OF TUMOR MASS. B. "LEFT BREAST" (MASTECTOMY) : BREAST TISSUE WITH BIOPSY CAVITY. NO EVIDENCE OF MALIGNANCY. 1 OF 15 LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (SEE NOTE). BENIGN PROLIFERATIVE CHANGES OF THE BREAST INCLUDING EXTENSIVE FIBROSIS,. DUCT ECTASIA, APOCRINE METAPLASIA, AND HYPERPLASIA OF THE USUAL TYPE. NOTE: One large lymph node (B18) appears negative for malignancy but is being. reprocessed for further examination. An addendum will be issued to this. report documenting the findings in this. ADDENDUM 1: Review of a reprocessed blocks (B18) shows three lymph nodes with no evidence. of malignancy. The one large lymph node mentioned in the original report. specifically contains no evidence of ma Lignaticy.

expanded version (tokens=1379) : 
 According to the breast pathology report, the following information can be extracted:

- Histological classification: Infiltrating ductal carcinoma (IDC)
- Subtype: Luminal A (LumA)
- Necrosis: The report does not mention any evidence of necrosis.
- Tumor infiltrating lymphocytes: There is no mention of tumor infiltrating lymphocytes.
- Histological grade: Grade 3
- Nuclear grade: Grade 2
- Lymphovascular invasion: There is no mention of lymphovascular invasion.
- Calcification: The report does not mention any evidence of calcification.
- Receptor status: Estrogen and progesterone receptor study results are pending, and thus not mentioned in the current report.
- IHC and ancillary testing results: There is no mention of any additional immunohistochemistry (IHC) or ancillary testing results, except for the note on the reprocessing of block B18 which confirmed that one large lymph node had no evidence of malignancy.

Additional information that can be extracted includes:
- Gross examination: The report provides details on the size, location, and appearance of the biopsy specimen and mastectomy specimen.
- Size and extent of cancer: The maximum tumor size is 3.5 cm, and approximately 15-20% of the tumor mass corresponds to in situ ductal carcinoma.
- Findings in lymph nodes: One of the fifteen lymph nodes examined was found to be positive for metastatic carcinoma,

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1527) : 
 Diagnosis: Infiltrating ductal carcinoma, Grade 3, Nuclear Grade 2, LumA subtype. No necrosis or lymphovascular invasion is observed. Estrogen and progesterone receptor status pending. Max tumor size is 3.5cm with in situ component representing 15-20% of mass. One of the fifteen lymph nodes tested positive for metastasis; however, reprocessing block B18 confirmed no malignancy in one large lymph node mentioned in the original report.

